SCHEMBL5588076

SCHEMBL5588076

CCCCc1c(O)c(O)c(OCCC)c(OCCC)c1OCCC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 5/20 0.37
HPGD P15428 2/20 0.36
NPC1 O15118 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
FFAR1 O14842 1/20 0.33
PTGS1 P23219 1/20 0.31
PTGS2 P35354 1/20 0.31
KDM4E B2RXH2 2/20 0.31
PKM P14618 1/20 0.31
LTA4H P09960 2/20 0.31
NR5A1 Q13285 1/20 0.31
MGAM O43451 1/20 0.31
GAA P10253 1/20 0.31
SI P14410 1/20 0.31
MGAM2 Q2M2H8 1/20 0.31
ALDH1A1 P00352 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5588091 0.95 ALOX5 (0.43) ALOX5HPGDPTGS1PTGS2KDM4E
SCHEMBL5587249 0.94 ALOX5 (0.40) ALOX5HPGDNPC1MAPK1HTT
SCHEMBL5588360 0.93 ALOX5 (0.45) ALOX5PTGS1PTGS2KDM4ENR5A1
SCHEMBL5588737 0.93 ALOX5 (0.45) ALOX5PTGS1PTGS2KDM4ENR5A1
SCHEMBL5586931 0.93 ALOX5 (0.45) ALOX5PTGS1PTGS2KDM4ENR5A1
SCHEMBL5586761 0.93 ALOX5 (0.45) ALOX5PTGS1PTGS2KDM4ENR5A1
SCHEMBL5587656 0.93 ALOX5 (0.45) ALOX5PTGS1PTGS2KDM4ENR5A1
SCHEMBL5588492 0.93 HPGD (0.36) ALOX5HPGDNPC1MAPK1HTT
SCHEMBL5588202 0.93 ALOX5 (0.41) ALOX5HPGDNPC1MAPK1HTT
SCHEMBL5588781 0.89 CYSLTR2 (0.33) LTA4HMGAMGAASIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 ALOX5 188/4885HPGD 2689/4885NPC1 3851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.